Head of FDA asks for probe

Saturday 10 July 2021

United States

Janet Woodcock, acting commissioner of the US Food and Drug Administration, has asked federal officials to conduct an investigation of interactions between agency staff and executives at Biogen Inc in the process that led up to the FDA’s approval of Aduhelm (aducanumab) for Alzheimer’

Read in full with a subscription

Learn more about subscribing to MedNous.